Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

11.5K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.5K
Nondisjunction01:21

Nondisjunction

3.8K
Nondisjunction is the failure of homologous chromosomes or sister chromatids to separate correctly and move to the opposite poles of the cells. This produces daughter cells with abnormal chromosome numbers.  Nondisjunction is common during anaphase I or anaphase II of meiosis.  Mutations in synaptonemal complex proteins that attach homologous chromosomes increase the chances of nondisjunction in anaphase I of meiosis I. In contrast, mutations in topoisomerases and condensins that hold...
3.8K
Abnormal Proliferation02:23

Abnormal Proliferation

4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Disorders of the Female Reproductive System01:24

Disorders of the Female Reproductive System

355
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
355
Cancer Prevention02:59

Cancer Prevention

6.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Trauma- and Violence-Informed Care Practices in the Emergency Department for Survivors of Intimate Partner Violence.

JAMA network open·2026
Same author

Trends, predictors, and safety of ovarian preservation in premenopausal women with high-grade endometrioid and non-endometrioid endometrial cancers.

Gynecologic oncology·2026
Same author

Extracellular Vesicle Mitochondrial DNA Levels Are Associated With Chronic Kidney Disease and Mitochondrial Haplogroup in Obese Individuals.

Journal of extracellular biology·2025
Same author

Activin levels correlate with lymphocytic infiltration in epithelial ovarian cancer.

Cancer medicine·2024
Same author

Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervix.

Proceedings of the National Academy of Sciences of the United States of America·2024
Same author

Randomized Phase II Trial of Imiquimod with or without 9-Valent HPV Vaccine versus Observation in Patients with High-grade Pre-neoplastic Cervical Lesions (NCT02864147).

Clinical cancer research : an official journal of the American Association for Cancer Research·2024

Related Experiment Video

Updated: Jun 26, 2025

Non-Invasive Ultrasound Assessment of Endometrial Cancer Progression in Pax8-Directed Deletion of the Tumor Suppressors Arid1a and Pten in Mice
07:44

Non-Invasive Ultrasound Assessment of Endometrial Cancer Progression in Pax8-Directed Deletion of the Tumor Suppressors Arid1a and Pten in Mice

Published on: February 17, 2023

1.5K

ARID1A in Gynecologic Precancers and Cancers.

Jaida E Morgan1, Nishah Jaferi1, Zainab Shonibare2

  • 1Yale College, Yale University, New Haven, Connecticut, USA.

Reproductive Sciences (Thousand Oaks, Calif.)
|May 13, 2024
PubMed
Summary

Genetic alterations in the tumor suppressor ARID1A are frequent in gynecologic cancers. ARID1A deficiency impacts multiple cellular functions, presenting therapeutic vulnerabilities for ovarian, uterine, cervical, and vaginal malignancies.

Keywords:
ARID1AChemoresistanceDisparitiesEndometriosisGynecologic cancersImmunotherapySWI/SNF complexTargeted therapies

More Related Videos

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
28:15

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer

Published on: July 28, 2010

12.4K
Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

6.7K

Related Experiment Videos

Last Updated: Jun 26, 2025

Non-Invasive Ultrasound Assessment of Endometrial Cancer Progression in Pax8-Directed Deletion of the Tumor Suppressors Arid1a and Pten in Mice
07:44

Non-Invasive Ultrasound Assessment of Endometrial Cancer Progression in Pax8-Directed Deletion of the Tumor Suppressors Arid1a and Pten in Mice

Published on: February 17, 2023

1.5K
Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
28:15

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer

Published on: July 28, 2010

12.4K
Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

6.7K

Area of Science:

  • Gynecologic Oncology
  • Cancer Genetics
  • Tumor Suppressor Genes

Background:

  • The tumor suppressor ARID1A frequently harbors genetic alterations in female reproductive tract malignancies.
  • ARID1A plays a critical role in various cellular processes, including DNA repair and immune modulation.
  • Its alterations are observed in precancerous lesions like endometriosis and atypical hyperplasia, as well as in ovarian, uterine, cervical, and vaginal cancers.

Purpose of the Study:

  • To summarize the prevalence of ARID1A alterations in gynecologic precancers and cancers.
  • To examine the mechanisms of ARID1A's tumor suppressive action.
  • To identify actionable signaling pathways and therapeutic vulnerabilities in ARID1A-mutated gynecologic cancers.

Main Methods:

  • Literature review of ARID1A alterations in gynecologic malignancies.
  • Analysis of ARID1A's downstream effects in benign and malignant gynecologic tissues.
  • Critical review of experimental and clinical evidence for therapeutic strategies.

Main Results:

  • ARID1A alterations are typically loss-of-function mutations, leading to reduced protein expression.
  • ARID1A deficiency affects DNA replication, repair, immune response, cell cycle, and stress pathways.
  • Potential therapeutic targets and vulnerabilities in ARID1A-mutated cancers have been identified.

Conclusions:

  • ARID1A mutations have a multifaceted role in the development of gynecologic precancers and cancers.
  • Understanding ARID1A's function is crucial for developing novel preventive and therapeutic strategies.
  • ARID1A status influences response to chemotherapy, radiation, and immunotherapy.